1. Granjeiro JM, Oliveira RC, Bustos-
Valenzuela
JC,
Sogayar MC,
Taga R. Bone
morphogeneti
c proteins: from structure to clinical use. Braz J Med Biol Res, 2005 Oct; 38(10): 1463-73.
2.
Marukaw
a E, Asahina I, Oda M, Seto I, Alam MI, Enomoto S. Bone regeneration using recombinant human bone morphoge-netic protein-2 (rhBMP-2) in alveolar defects of primate mandibles. Br J Oral Maxillofac Surg, 2001 Dec; 39(6): 452-59.
3. Özeç İ, Kılıç E, Gümüş C, Göze F. Lokal olarak üç farklı dozda simvastatin uygulamasının kemik defekti iyileşmesi üzerine etkisinin değerlendirilmesi. Cumhuriyet Üniversitesi Diş Hekimliği Fakültesi Dergisi,
2007; 10(2): 82-86.
4.
Wozne
y JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, He-
68
Kemik Morfojenetik Proteinler ve Diş Hekimliğinde Kullanım Alanları
wick RM, Wang EA. Novel regulators of bone formation: molecular clones and activities. Science, 1988 Dec 16; 242(4885): 1528-34.
5.
Avil
a G, Misch K, Galindo-Moreno P, Wang HL. Implant surface treatment using biomimetic agents. Implant Dent, 2009; 18(1): 17-26.
6. Özeç İ, Yeler H. Bone morphogene-tik proteinler ve osteoindüksiyon. Cumhuriyet Üniversitesi Diş Hekimliği Fakültesi Dergisi, 2003; 6(1): 31-36.
7. Nakashima M, Reddi AH.
Th
e application of bone morphogenetic proteins to dental tissue engineering. Nat Biotech, 2003;21:1025-32.
8.
Nakashim
a M. Bone morphogenetic proteins in dentin regeneration for potential use in endodontic therapy. Cytokine Growth Factor Rev, 2005 Jun; 16(3): 369-76.
9.
Nakashim
a M. Induction of dentin formation on canine amputated pulp by recombinant human bone morphogenetic proteins (BMP)-2 and -4. J Dent Res, 1994 Sep; 73(9): 1515-22.
10. Rutherford RB, Gu K. Treatment of inflamed ferret dental pulps with recombinant bone morphogenetic protein-7. Eur J Oral Sci, 2000 Jun; 108(3): 202-206.
11.
Sloa
n AJ, Rutherford RB, Smith AJ. Stimulation of the rat dentine-pulp complex by bone morphogenetic protein-7 in vitro. Arch Oral Biol, 2000 Feb; 45 (2): 173-77.
12. Yıldırım S, Alaçam A. Vital pulpa tedavilerinde protein ve gen terapileri. Ha¬cettepe Dişhekimliği Fakültesi Dergisi, 2007; 31(2): 54-63.
13.
Nakashim
a M, Iohara K, Ishikawa M, Ito M, Tomokiyo A, Tanaka T, Akamine A. Stimulation of reparative dentin forma¬tion by ex vivo gene therapy using dental stem cells electrotransfected with delivery of growth/differentiation factor 11 (Gdf11).
Human Gene Therapy, 2004, 15(11): 1045¬1053.
14. Nakashima M, Tachibana K, Iohara K, Ito M, Ishikawa M, Akamine A. Induction of reparative dentin formation by ultrasound-mediated gene delivery of growth/differentiation factor 11. Hum Gene Ther, 2003 Apr 10; 14(6): 591-97.
15.
Rutherfor
d RB. BMP-7 gene transfer to inflamed ferret dental pulps. Eur J Oral Sci, 2001 Dec; 109(6): 422-24.
16.
Bashutsk
i JD, Wang HL. Periodontal and endodontic regeneration. J Endodon, 2009; 35: 321-328.
17. Lütfioğlu M. Periodontal rejeneras-yon ve büyüme faktörleri. Atatürk Üniv. Diş
Hek. Fak. Derg, 2007; 17(3): 35-43.
18. Taba M Jr,
Jin Q, Sugai JV, Gian-nobile WV. Current concepts in periodontal bioengineering. Orthod Craniofac Res, 2005 Nov; 8(4): 292-302.
19.
Ripamont
i U, Heliotis M, van den Heever B, Reddi AH. Bone morphogenetic proteins induce periodontal regeneration in the baboon (Papio ursinus). J Periodontal Res, 1994 Nov; 29(6): 439-45.
20. Blumenthal NM, Koh-Kunst G, Al-
ves ME, Miranda D, Sorensen RG, Wozney JM, Wikesjö UM. Effect of surgical implantation of recombinant human bone morphogenetic protein-2 in a bioabsorbable collagen sponge or calcium phosphate putty carrier in intrabony periodontal defects in the baboon. J Periodontol, 2002 Dec; 73(12): 1494-506.
21. Büyüközdemir S, Demiralp B. Peri-odontal problemli dişlerde replantasyon ve replantasyonda kullanılan ajanlar. Hacettepe Dişhekimliği Fakültesi Dergisi, 2007; 31(3):
88-101.
22.
Wolfma
n NM, Hattersley G, Cox K, Celeste AJ, Nelson R, Yamaji N, Dube JL, DiBlasio-Smith E, Nove J, Song JJ, Wozney JM, Rosen V. Ectopic induction of tendon
69
and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family. J Clin Invest, 1997 Jul 15; 100(2): 321-30.
23.
Hun
t DR, Jovanovic SA, Wikesjö UM, Wozney JM, Bernard GW. Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A pilot study. J Periodontol, 2001 May; 7 (5): 651-58.
24.
Mati
n K, Nakamura H, Irie K, Oza-wa H, Ejiri S. Impact of recombinant human bone morphogenetic protein-2 on residual ridge resorption after tooth extraction: an experimental study in the rat. Int J Oral Maxillofac Implants, 2001 May-Jun; 16
(3): 400-11.
25.
Cochra
n DL, Schenk R, Buser D, Wozney JM, Jones AA. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants. J Periodontol, 1999 Feb;
70(2): 139-50.
26.
Koempel JA, Patt BS,
O'Grad
y K, Wozney J, Toriumi DM. The effect of recombinant human bone morphogenetic protein-2 on the integration of porous hy-droxyapatite implants with bone. J Biomed Mater Res, 1998 Sep 5; 41(3): 359-63.
27.
Susin
C
, Qahash M, Polimeni G, Lu PH, Prasad HS, Rohrer MD, Hall J, Wikesjö UM. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-7 (rhBMP-7/ rhOP-1): histological observations. J Clin Periodontol, 2010 Jun; 37(6): 574-81.
28.
Triplet
t RG, Nevins M, Marx RE, Sp-agnoli DB, Oates TW, Moy PK, Boyne PJ. Pivotal, randomized, parallel evaluation of recombinant human bone morphogenetic protein-2/absorbable collagen sponge and autogenous bone graft for maxillary si-
S. Zorlu, G. Aren
nus floor augmentation. J Oral Maxillofac Surg, 2009 Sep; 67(9): 1947-60.
29.
Wad
a K, Niimi A, Watanabe K, Sawai T, Ueda M. Maxillary sinus floor augmen¬tation in rabbits: a comparative histologic-histomorphometric study between rhBMP-2 and autogenous bone. Int J Periodontics Re¬storative Dent, 2001 Jun; 21(3): 252-63.
30.
Wikesjö UM,
Qahas
h M, Huang YH, Xiropaidis A, Polimeni G, Susin C. Bone morphogenetic proteins for periodontal and alveolar indications; biological observations - clinical implications. Orthod Cranio-fac Res, 2009 Aug; 12(3): 263-70.
31.
Rasubal
a L, Yoshikawa H, Naga-ta K, Iijima T, Ohishi M. Platelet-derived growth factor and bone morphogenetic pro¬tein in the healing of mandibular fractures in rats. Br J Oral Maxillofac Surg, 2003 Jun; 41(3): 173-78.
32.
Campis
i P, Hamdy RC, Lauzier D, Amako M, Rauch F, Lessard ML. Expression of bone morphogenetic proteins during mandibular distraction osteogenesis. Plast Reconstr Surg, 2003 Jan; 111(1): 201-208.
33.
Carstens
MH
, Chin M, Ng T, Tom WK. Reconstruction of #7 facial cleft with distraction-assisted in situ osteogenesis (DISO): role of recombinant human bone morphogenetic protein-2 with Helistat-activated collagen implant. J Craniofac Surg, 2005 Nov; 16(6): 1023-32.
34.
Chan
g SC, Wei FC, Chuang H, Chen YR, Chen JK, Lee KC, Chen PK, Tai CL, Lou J. Ex vivo gene therapy in autologous critical-size craniofacial bone regeneration. Plast Reconstr Surg, 2003 Dec; 112(7): 1841¬50.
35. Govender S et al. Recombinant hu¬man bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg
70
Kemik Morfojenetik Proteinler ve
Diş
Hekimliğinde Kullanım Alanları
Am,
200
2 Dec; 84(12): 2123-34.
36.
Alde
n TD, Beres EJ, Laurent JS, Engh JA, Das S, London SD, Jane JA Jr, Hudson SB, Helm GA. The use of bone morphogenetic protein gene therapy in craniofacial bone repair. J Craniofac Surg, 2000; 11(1): 24-30.
37.
Dickinso
n BP, Ashley RK, Wasson KL, O'Hara C, Gabbay J, Heller JB, Bradley JP Reduced morbidity and improved healing with bone morphogenic protein-2 in older patients with alveolar cleft defects. Plast. Reconstr. Surg, 2008; 121: 209-217.
38.
Chi
n M, Ng T, Tom WK, Carstens M. Repair of alveolar clefts with recombinant human bone morphogenetic protein (rh-BMP-2) in patients with clefts. J Craniofac Surg, 2005 Sep; 16(5): 778-89.
39.
Fallucc
o MA, Carstens MH. Primary reconstruction of alveolar clefts using recombinant human bone morphogenic pro-tein-2: clinical and radiographic outcomes. J Craniofac Surg, 2009 Sep; 20(2): 1759-64.
40.
Rese
l E, Martínez-Sanz E, González I, Trinidad E, Garcillán B, Amorós M, Alon-so-Bañuelos C, González-Meli B, Lagarón E, Murillo J, Del Río A, Barrio C, López M, Martinez-Alvarez C. In vitro manipulation of cleft palate connective tissue: setting the bases of a proposed new treatment. J Surg Res, 2007 Mar; 138(1): 111-20.
41.
Vinatie
r C, Bouffi C, Merceron C, Gordeladze J, Brondello JM, Jorgensen C, Weiss P, Guicheux J, Noël D. Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal stem cell therapy. Curr Stem Cell Res Ther, 2009 Dec; 4(4): 318-29.
42.
Suzuk
i T, Bessho K, Fujimura K, Okubo Y, Segami N, Iizuka T. Regeneration of defects in the articular cartilage in rabbit temporomandibular joints by bone morphogenetic protein-2. Br J Oral Maxil-lofac Surg, 2002 Jun; 40(3): 201-6.
43.
Uek
i K, Takazakura D, Marukawa K, Shimada M, Nakagawa K, Takatsuka S, Yamamoto E. The use of polylactic acid/ polyglycolic acid copolymer and gelatin sponge complex containing human recombinant bone morphogenetic protein-2 following condylectomy in rabbits. J Craniomaxillofac Surg, 2003 Apr; 31(2): 107-14.
Thank you for copying data from http://www.arastirmax.com
